-
Taxonomy & unit
-
us-gaap: USD
-
Description
-
Amount of expense for award under share-based payment arrangement. Excludes amount capitalized.
-
Summary
-
Transcode Therapeutics, Inc. annual/quarterly Share-based Payment Arrangement, Expense history and growth rate from Q1 2021 to Q1 2022.
- Transcode Therapeutics, Inc. Share-based Payment Arrangement, Expense for the quarter ending March 31, 2022 was $60.6K, a 25.1% increase year-over-year.
- Transcode Therapeutics, Inc. Share-based Payment Arrangement, Expense for the twelve months ending March 31, 2022 was $198K.
- Transcode Therapeutics, Inc. annual Share-based Payment Arrangement, Expense for 2022 was $395K, a 113% increase from 2021.
- Transcode Therapeutics, Inc. annual Share-based Payment Arrangement, Expense for 2021 was $186K, a 309% increase from 2020.
Share-based Payment Arrangement, Expense, Trailing 12 Months (USD)
Share-based Payment Arrangement, Expense, Quarterly (USD)
Share-based Payment Arrangement, Expense, YoY Quarterly Growth (%)